Efthymios Deliargyris, Chief Medical Officer at Cytosorbents Corp (CTSO), bought 22,557 shares at $1.33 ($30K) on 2023-12-13, disclosed to the SEC on 2023-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.